A key protein, LRG1, was identified as the early cause of diabetic eye damage, and blocking it may stop the disease before ...
November marks Diabetic Eye Disease Awareness Month, highlighting the silent vision risks of diabetes and the importance of ...
Diabetes is a systemic disease, which means it affects many organs, including the heart, blood vessels, nerves, kidneys and ...
A long-time supporter of the St John Eye Van, UD Trucks has been formally recognised for its support of the vital regional ...
The FDA has approved Eylea HD (aflibercept) 8 mg to treat patients with macular edema following retinal vein occlusion (RVO) with dosing of up to every 8 weeks after an initial monthly dosing period.
FDA approves Regeneron's Eylea HD for retinal vein occlusion, adding extended dosing options and greater flexibility across ...
Sun Pharma has launched an eye-opening awareness push about a common—and commonly overlooked—complication of diabetes. | Sun Pharma has launched an eye-opening awareness push about a common—and ...
First and only FDA-approved treatment for RVO indicated for up to every 8-week dosing after an initial monthly dosing period Monthly dosing ...
VISION 2020: The Right to Sight – India has released the revised National Guidelines for the Management of Diabetic ...
India has introduced revised national guidelines aimed at reducing blindness caused by diabetic retinopathy, a complication of diabetes affecting millions of Indians.
Diabetic Retinopathy Patient Summit organized by Dr Agarwals Eye Hospitals, across India Group offers Free diabetic eye ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback